290 related articles for article (PubMed ID: 26189209)
1. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study.
Arns M; Bruder G; Hegerl U; Spooner C; Palmer DM; Etkin A; Fallahpour K; Gatt JM; Hirshberg L; Gordon E
Clin Neurophysiol; 2016 Jan; 127(1):509-519. PubMed ID: 26189209
[TBL] [Abstract][Full Text] [Related]
2. Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment.
van der Vinne N; Vollebregt MA; van Putten MJAM; Arns M
Neuroimage Clin; 2019; 24():102056. PubMed ID: 31795035
[TBL] [Abstract][Full Text] [Related]
3. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
[TBL] [Abstract][Full Text] [Related]
4. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
[TBL] [Abstract][Full Text] [Related]
5. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Arns M; Gordon E; Boutros NN
Clin EEG Neurosci; 2017 Jan; 48(1):33-40. PubMed ID: 26674366
[TBL] [Abstract][Full Text] [Related]
6. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
[TBL] [Abstract][Full Text] [Related]
7. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
8. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
9. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
Trials; 2011 Jan; 12():4. PubMed ID: 21208417
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
11. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
[TBL] [Abstract][Full Text] [Related]
12. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study.
Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M
J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202
[TBL] [Abstract][Full Text] [Related]
13. EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medication.
Iseger TA; Korgaonkar MS; Kenemans JL; Grieve SM; Baeken C; Fitzgerald PB; Arns M
Eur Neuropsychopharmacol; 2017 Apr; 27(4):301-312. PubMed ID: 28237506
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
[TBL] [Abstract][Full Text] [Related]
15. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
Saveanu R; Etkin A; Duchemin AM; Goldstein-Piekarski A; Gyurak A; Debattista C; Schatzberg AF; Sood S; Day CV; Palmer DM; Rekshan WR; Gordon E; Rush AJ; Williams LM
J Psychiatr Res; 2015 Feb; 61():1-12. PubMed ID: 25586212
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study.
Ip CT; Olbrich S; Ganz M; Ozenne B; Köhler-Forsberg K; Dam VH; Beniczky S; Jørgensen MB; Frokjaer VG; Søgaard B; Christensen SR; Knudsen GM
Eur Neuropsychopharmacol; 2021 Aug; 49():101-112. PubMed ID: 33910154
[TBL] [Abstract][Full Text] [Related]
17. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM
Trials; 2013 Jul; 14():224. PubMed ID: 23866851
[TBL] [Abstract][Full Text] [Related]
18. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
[TBL] [Abstract][Full Text] [Related]
19. Psychomotor retardation is linked to frontal alpha asymmetry in major depression.
Cantisani A; Koenig T; Horn H; Müller T; Strik W; Walther S
J Affect Disord; 2015 Dec; 188():167-72. PubMed ID: 26363266
[TBL] [Abstract][Full Text] [Related]
20. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
Caudill MM; Hunter AM; Cook IA; Leuchter AF
Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
